LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.7700
-0.0101 (-1.29%)
At close: Oct 17, 2025

LakeShore Biopharma Statistics

Total Valuation

LSBCF has a market cap or net worth of 31.73 million. The enterprise value is 84.97 million.

Market Cap31.73M
Enterprise Value 84.97M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

LSBCF has 41.21 million shares outstanding. The number of shares has increased by 89.95% in one year.

Current Share Class 41.21M
Shares Outstanding 41.21M
Shares Change (YoY) +89.95%
Shares Change (QoQ) +59.60%
Owned by Insiders (%) 87.63%
Owned by Institutions (%) 1.92%
Float 4.71M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.37
PB Ratio 0.46
P/TBV Ratio 0.54
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -6.17
EV / Sales 1.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.61

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.83.

Current Ratio 1.02
Quick Ratio 0.64
Debt / Equity 0.83
Debt / EBITDA n/a
Debt / FCF -3.10
Interest Coverage -3.15

Financial Efficiency

Return on equity (ROE) is -18.43% and return on invested capital (ROIC) is -3.22%.

Return on Equity (ROE) -18.43%
Return on Assets (ROA) -2.15%
Return on Invested Capital (ROIC) -3.22%
Return on Capital Employed (ROCE) -9.13%
Revenue Per Employee 147,899
Profits Per Employee -24,046
Employee Count573
Asset Turnover 0.43
Inventory Turnover 0.50

Taxes

Income Tax -130,486
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -79.19% in the last 52 weeks. The beta is 0.56, so LSBCF's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change -79.19%
50-Day Moving Average 0.78
200-Day Moving Average 1.48
Relative Strength Index (RSI) 49.31
Average Volume (20 Days) 37,686

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.71

Income Statement

In the last 12 months, LSBCF had revenue of 84.75 million and -13.78 million in losses. Loss per share was -0.72.

Revenue84.75M
Gross Profit 69.89M
Operating Income -6.83M
Pretax Income -13.91M
Net Income -13.78M
EBITDA -1.78M
EBIT -6.83M
Loss Per Share -0.72
Full Income Statement

Balance Sheet

The company has 3.87 million in cash and 57.11 million in debt, giving a net cash position of -53.24 million or -1.29 per share.

Cash & Cash Equivalents 3.87M
Total Debt 57.11M
Net Cash -53.24M
Net Cash Per Share -1.29
Equity (Book Value) 68.87M
Book Value Per Share 3.32
Working Capital 2.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.67 million and capital expenditures -1.75 million, giving a free cash flow of -18.42 million.

Operating Cash Flow -16.67M
Capital Expenditures -1.75M
Free Cash Flow -18.42M
FCF Per Share -0.45
Full Cash Flow Statement

Margins

Gross margin is 82.47%, with operating and profit margins of -8.06% and -16.26%.

Gross Margin 82.47%
Operating Margin -8.06%
Pretax Margin -16.41%
Profit Margin -16.26%
EBITDA Margin -2.10%
EBIT Margin -8.06%
FCF Margin n/a

Dividends & Yields

LSBCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -89.95%
Shareholder Yield -89.95%
Earnings Yield -43.42%
FCF Yield -58.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 4, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date Oct 4, 2024
Split Type Reverse
Split Ratio 0.1

Scores

LSBCF has an Altman Z-Score of -1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.67
Piotroski F-Score 2